Home > Financial Ratios > NATH BIOGENES (INDIA)
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2023Mar2022Mar2013Mar2012
   Working Capital/Sales(x) 0.991.026.375.12

What is the latest Working Capital/Sales ratio of NATH BIOGENES (INDIA) ?

The latest Working Capital/Sales ratio of NATH BIOGENES (INDIA) is 0.99 based on Mar2023 Consolidated results.
Year Working Capital/Sales
Mar20230.99
Mar20221.02
Mar20136.37
Mar20125.12

How is Working Capital/Sales of NATH BIOGENES (INDIA) Trending?

Years Working Capital/Sales % Change
Mar2023 0.99
-2.94
Mar2022 1.02
-83.99
Mar2013 6.37
24.41
Mar2012 5.12 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Working Capital/Sales ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹383.2 Cr -2.7% 10.6% 24.2% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,737.9 Cr -1.9% -4.5% 50.4% Stock Analytics
KAVERI SEED COMPANY ₹4,308.3 Cr -4.8% 29.6% 59.7% Stock Analytics
VENKYS (INDIA) ₹2,553.0 Cr 0.5% 12.6% 16.2% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹2,261.9 Cr -0.8% -9.2% -42.6% Stock Analytics
TIERRA AGROTECH ₹484.3 Cr 8.2% 7.6% -38.6% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-2.7%

10.6%

24.2%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses